These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11079753)

  • 1. Is the paradoxical first trimester drop in insulin requirement due to an increase in C-peptide concentration in pregnant Type I diabetic women?
    Ilic S; Jovanovic L; Wollitzer AO
    Diabetologia; 2000 Oct; 43(10):1329-30. PubMed ID: 11079753
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exogenous insulin on excursions and diurnal rhythm of plasma glucose in pregnant diabetic patients with and without residual beta-cell function.
    Rigg L; Cousins L; Hollingsworth D; Brink G; Yen SS
    Am J Obstet Gynecol; 1980 Feb; 136(4):537-44. PubMed ID: 6986776
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.
    Horvaticek M; Djelmis J; Ivanisevic M; Oreskovic S; Herman M
    Eur J Clin Nutr; 2017 Aug; 71(8):968-972. PubMed ID: 28378851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.
    Murphy HR; Elleri D; Allen JM; Simmons D; Nodale M; Hovorka R
    Diabet Med; 2012 Oct; 29(10):e361-4. PubMed ID: 22804483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy.
    Lisowska-Myjak B; Sygitowicz G; Wolf B; Pachecka J
    Eur J Obstet Gynecol Reprod Biol; 2001 Nov; 99(1):53-6. PubMed ID: 11604186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining insulin requirement in the late first trimester of diabetic pregnancy.
    Jovanovic L; Knopp RH; Brown Z; Conley MR; Park E; Mills JL; Metzger BE; Aarons JH; Holmes LB; Simpson JL;
    Diabetes Care; 2001 Jul; 24(7):1130-6. PubMed ID: 11423491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The insulin receptor function of mononuclear leukocytes in pregnant women with diabetes mellitus].
    Mikaelian NP; Kniazev IuA; Bespalova VA; Kirbasova NP; Petrukhin VA
    Probl Endokrinol (Mosk); 1990; 36(2):28-31. PubMed ID: 2194201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.
    Evers IM; ter Braak EW; de Valk HW; van Der Schoot B; Janssen N; Visser GH
    Diabetes Care; 2002 Mar; 25(3):554-9. PubMed ID: 11874946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Receptor binding of insulin to erythrocytes in healthy women and in patients with diabetes mellitus during pregnancy].
    Tikhonova NE; Kosheleva NG
    Probl Endokrinol (Mosk); 1987; 33(5):18-23. PubMed ID: 3321032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual B-cell function and glycaemic control in diabetic pregnancy.
    Pirttiaho HI; Hartikainen-Sorri AL; Kaila JM; Puukka R
    Horm Metab Res; 1986 Apr; 18(4):250-2. PubMed ID: 3519412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effects of conventional insulin therapy and the insulin infusion pump on blood glucose values in pregnant diabetics].
    Vozár J; Kusinová F; Komorník J; Mikulecký M; Ondrejka P
    Bratisl Lek Listy; 1986 May; 85(5):570-7. PubMed ID: 3521790
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of fuel homeostasis in IDDM patients during pregnancy by an open-loop insulin infusion system.
    Foss MC; Aoki TT
    Diabetes Care; 1993 Jan; 16(1):103-9. PubMed ID: 8422762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of study of the hemostatic system for the management of pregnant women with diabetes mellitus].
    Petrukhin VA; Efimov VS; Fedorova MV; Grishin VL; Kotov IuB
    Klin Lab Diagn; 1995; (6):87-9. PubMed ID: 8589980
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin management of type I and type II diabetes in pregnancy.
    Hare JW
    Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of diabetes mellitus in pregnant women evaluated by the Schlichtkrul coefficient and obstetrical results].
    Kalita J; Krzyczkowska-Sendrakowska M; Michałek-Machejek D; Zdebski Z
    Ginekol Pol; 1988 Jun; 59(6):333-7. PubMed ID: 3069615
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission of diabetes mellitus in pregnancy.
    Sagoskin AW
    Obstet Gynecol; 1985 Aug; 66(2):280-2. PubMed ID: 3895075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on serum C-peptide concentrations in pregnant diabetic women and in newborns of diabetic mothers.
    Gerö L; Baranyi E; Békefi D; Dimény E; Szalay J; Tamăs G
    Horm Metab Res; 1982 Oct; 14(10):516-20. PubMed ID: 6757083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the radioimmunologic study of the impairment of insulin secretion as an atherogenic factor].
    Kniazev IuA; Bespalova VA; Vakhrusheva LL; Kirbasova NP; Severtsova VV
    Med Radiol (Mosk); 1984 Nov; 29(11):37-40. PubMed ID: 6390068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and circulatory effects of oral salbutamol in the third trimester of pregnancy in diabetic and non-diabetic women.
    Wager J; Fredholm BB; Lunell NO; Persson B
    Br J Obstet Gynaecol; 1981 Apr; 88(4):352-61. PubMed ID: 6261782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of maintaining optimal metabolic control in pregnant patients with insulin-dependent diabetes].
    Micaló T; Sallent N; Gutiérrez A; Noguera J; Figuerola D
    Med Clin (Barc); 1986 Dec; 87(19):787-90. PubMed ID: 3546971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.